Financial MarketsInvesting.comWed, Sep 3, 2025, 7:47 PMPositive

Oppenheimer maintains Olema stock rating, sees Pfizer deal as strategic

Oppenheimer has reaffirmed its stock rating for Olema, viewing the recent Pfizer deal as a strategic move that could benefit the company.

Oppenheimer maintains Olema stock rating, sees Pfizer deal as strategic

WPN Brief

Oppenheimer has reaffirmed its stock rating for Olema, viewing the recent Pfizer deal as a strategic move that could benefit the company.
Ask WPN AI